Table I.
Laboratory data of controls and patients with CAP prior to and following treatment.
| Clinical variable | C (n=52) | Before antibiotic treatment (n=90) | After antibiotic treatment (n=90) | P UT/Ca | P UT/Tb |
|---|---|---|---|---|---|
| Age | 60.25±10.69c | 65.02±18.10c | =0.085 | ||
| Gender | |||||
| Male | 35 (67.3%) | 65 (72.2%) | =0.536 | ||
| Female | 17 (32.7%) | 25 (27.8%) | |||
| CRP (mg/dl) | 0.47±0.27 | 12.99±6.50 | 2.82±3.16 | <0.001 | <0.001 |
| WBCs (cells/mm3) | 6,301.2±1,827.2 | 13,316.3±4,797.26 | 9,413.7±3,791.4 | <0.001 | <0.001 |
| Neutrophils (cells/mm3) | 3,683.2±1,353.2 | 10,657.3±4,261.7 | 6,930.2±3,718.1 | <0.001 | <0.001 |
| PSI score | |||||
| I | 12 (13.3%) | ||||
| II | 14 (15.5%) | ||||
| III | 24 (26.7%) | ||||
| IV | 33 (36.7%) | ||||
| V | 7 (7.8%) |
CAP, community-acquired pneumonia; CRP, C-reactive protein; WBCs, white blood cells; C, controls; UT, patients with community-acquired pneumonia prior to receiving antibiotic treatment; T, patients with community-acquired pneumonia following antibiotic treatment.
a
The statistical difference was analyzed by the Mann-Whitney U-test.
b
The statistical difference was analyzed by the Wilcoxon signed-ranks test.
c
Data are expressed as the mean ± standard deviation. P<0.05 was considered to indicate a statistically significant difference.